{'fraction_non_alphanumeric': 0.03129657228017884, 'fraction_numerical': 0.00894187779433681, 'mean_word_length': 5.4, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Persistent polyarticular synovitis after treatment with alendronate].

A 62-year-old, previously healthy woman diagnosed with post-menopausal osteoporosis received alendronate 70 mg/week. One week after the first dose, she developed polyarticular synovitis in the hands, feet and knees. We suspect this to be an adverse reaction to alendronate. At follow-up after 14 months, the patient still had residual synovitis, mainly in the hands and finger joints, despite continued low-dose prednisolone therapy. Two additional cases of synovitis associated with bisphosphonate therapy have been reported in the literature. The pathophysiology behind this phenomenon is unknown.